These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37543258)

  • 1. Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study.
    Bailleul A; Fulgencio JP; Vimont S; Mordelet C; Ray B; Lassel L; Lapidus N; Quesnel C; Garnier M
    Infect Dis Now; 2023 Oct; 53(8):104766. PubMed ID: 37543258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
    Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
    Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of totally implantable venous-access port-related infections.
    Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
    Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
    Lafaurie M; Montlahuc C; Kerneis S; de Lastours V; Abgrall S; Manceron V; Couzigou C; Chabrol A; de Raigniac A; Lescure X; Longuet P; Lesprit P; Vanjak D; Lepeule R;
    J Antimicrob Chemother; 2023 May; 78(5):1253-1258. PubMed ID: 37014800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
    Longo R; Llorens M; Goetz C; Platini C; Eid N; Sellies J; Ouamara N; Quétin P
    Oncology; 2017; 93(2):99-105. PubMed ID: 28463827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature.
    Lebeaux D; Larroque B; Gellen-Dautremer J; Leflon-Guibout V; Dreyer C; Bialek S; Froissart A; Hentic O; Tessier C; Ruimy R; Pelletier AL; Crestani B; Fournier M; Papo T; Barry B; Zarrouk V; Fantin B
    Medicine (Baltimore); 2012 Nov; 91(6):309-318. PubMed ID: 23117849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center.
    Ji L; Yang J; Miao J; Shao Q; Cao Y; Li H
    Cell Biochem Biophys; 2015 May; 72(1):235-40. PubMed ID: 25542370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver-Mixed Port Reduces Venous Access Port Related Infection Rate Compared to Non-Silver-mixed Port: A Single-center Retrospective Analysis.
    Suzuki T; Michimoto K; Hasumi J; Kisaki S; Hasegawa Y; Fujimori A; Yoshimatsu L; Ashida H; Ojiri H
    Cardiovasc Intervent Radiol; 2023 Dec; 46(12):1696-1702. PubMed ID: 37902854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching.
    Nezami N; Xing M; Groenwald M; Silin D; Kokabi N; Latich I
    Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1302-1310. PubMed ID: 31187229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factor for infection of totally implantable venous access port.
    Chang TC; Yen MH; Kiu KT
    Langenbecks Arch Surg; 2022 Feb; 407(1):343-351. PubMed ID: 34550464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIVAP-related infection due to Gram-negative aerobic bacilli: should TIVAP stay or should it go?
    Rolland S; Kassis-Chikhani N; Auclin E; Bensaid S; Bidaud AL; Gerlinger MP; Blez D; Mainardi JL; Lebeaux D; Dubert M
    Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):161-168. PubMed ID: 36472717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
    Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
    Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port].
    Crisinel M; Mahy S; Ortega-Debalon P; Buisson M; Favre JP; Chavanet P; Piroth L
    Med Mal Infect; 2009 Apr; 39(4):252-8. PubMed ID: 19108966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: A systematic review and meta-analysis.
    Jiang M; Li CL; Pan CQ; Cui XW; Dietrich CF
    J Thromb Haemost; 2020 Sep; 18(9):2253-2273. PubMed ID: 32479699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
    Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
    Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, Safety, and Cost-Effectiveness of Intracavitary Electrocardiography-Guided Catheter Tip Placement for Totally Implantable Venous Access Port.
    Liu Z; Zheng X; Zhen Y; Liu X; Lin F; Ye Z; Liu P
    Ann Vasc Surg; 2022 Jul; 83():168-175. PubMed ID: 34936891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
    Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
    Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
    Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
    J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.